Isotretinoin Belupo (Isotretinoin)

Isotretinoin acts by binding to nuclear retinoic acid receptors, which leads to a decrease in the size and activity of sebaceous glands, reduced sebum production, normalization of follicular keratinization, and anti‑inflammatory effects within the pilosebaceous unit. These actions collectively diminish the environment that supports acne development.

The dosage of Isotretinoin Belupo is individualized by the prescribing clinician based on the patient’s body weight, severity of acne, and tolerance. Typically, treatment begins with a low dose that is gradually increased to achieve the desired clinical response while monitoring safety parameters.

Isotretinoin Belupo is classified as pregnancy category X and is contraindicated during pregnancy because of a high risk of severe birth defects. It is also not recommended for breastfeeding mothers, as the drug can be excreted in breast milk and may harm the infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with oral antibiotics, isotretinoin offers a disease‑modifying effect rather than merely suppressing bacterial growth, often leading to longer‑lasting remission. Unlike other retinoids such as acitretin, isotretinoin is specifically approved for severe acne and has a well‑characterized efficacy profile, though both share similar safety considerations.

Isotretinoin Belupo should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

The medication is taken orally, usually with a meal to improve absorption and reduce gastrointestinal irritation. Capsules should be swallowed whole with water and not crushed or chewed. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most critical risks include teratogenicity (birth defects), severe depression or suicidal thoughts, pancreatitis, acute hepatitis, and pseudotumor cerebri (intracranial hypertension). Regular monitoring of liver function, lipid levels, and mental health is essential throughout therapy.

Individuals who are pregnant, planning to become pregnant, or not using effective contraception should avoid the drug. It is also contraindicated in patients with pre‑existing severe liver disease, uncontrolled hyperlipidaemia, or a history of hypersensitivity to retinoids.